We are live on ! Find out more
CM

Crestline Management Portfolio holdings

AUM $46.3M
1-Year Est. Return 48.82%
This Fund
S&P 500
This Quarter Est. Return
+0.39%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$3.01B
AUM Growth
+$1.08B
Cap. Flow
+$1.16B
Cap. Flow %
38.44%
Top 10 Hldgs %
31.04%
Holding
889
New
375
Increased
214
Reduced
113
Closed
184

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$144M
2
AA icon
Alcoa
AA
+$18.6M
3
NSC icon
Norfolk Southern
NSC
+$17.7M
4
AVGO icon
Broadcom
AVGO
+$15.8M
5
GLNG icon
Golar LNG
GLNG
+$14.7M

Sector Composition

Rank Sector Weight
1 Technology 21.64%
2 Healthcare 10.52%
3 Industrials 9.72%
4 Financials 6.92%
5 Consumer Discretionary 6.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AZZ icon
201
AZZ Inc
AZZ
$4.35B
$3.48M 0.12%
+42,541
New +$3.6M
WFC icon
202
Wells Fargo
WFC
$261B
$3.48M 0.12%
49,564
+22,495
+83% +$1.54M
AEM icon
203
Agnico Eagle Mines
AEM
$73.6B
$3.46M 0.12%
44,247
-47,618
-52% -$3.93M
CCS icon
204
Century Communities
CCS
$1.91B
$3.43M 0.11%
+46,692
New +$4.16M
MHK icon
205
Mohawk Industries
MHK
$7.5B
$3.42M 0.11%
+28,681
New +$4.01M
VZ icon
206
Verizon
VZ
$195B
$3.38M 0.11%
84,560
+58,444
+224% +$2.47M
CELH icon
207
Celsius Holdings
CELH
$7.47B
$3.33M 0.11%
+126,416
New +$3.75M
VECO icon
208
Veeco
VECO
$3.05B
$3.31M 0.11%
123,392
-8,664
-7% -$252K
TROW icon
209
T. Rowe Price
TROW
$23.9B
$3.28M 0.11%
29,002
+21,912
+309% +$2.54M
TVTX icon
210
Travere Therapeutics
TVTX
$5.2B
$3.24M 0.11%
185,840
+65,115
+54% +$1.15M
PCTY icon
211
Paylocity
PCTY
$7.38B
$3.18M 0.11%
+15,962
New +$3.05M
CFLT
212
DELISTED
Confluent
CFLT
$3.18M 0.11%
+113,777
New +$3.05M
TLN
213
Talen Energy Corp
TLN
$16B
$3.13M 0.1%
+15,541
New +$3.03M
DT icon
214
Dynatrace
DT
$12.9B
$3.09M 0.1%
+56,855
New +$3.1M
EXE
215
Expand Energy Corp
EXE
$21.8B
$3.06M 0.1%
30,728
+4,476
+17% +$413K
EMN icon
216
Eastman Chemical
EMN
$8B
$3.06M 0.1%
+33,478
New +$3.43M
PNR icon
217
Pentair
PNR
$10.4B
$3.01M 0.1%
29,922
+5,268
+21% +$540K
BSX icon
218
Boston Scientific
BSX
$69.5B
$2.97M 0.1%
+33,292
New +$2.93M
AMWD
219
DELISTED
American Woodmark
AMWD
$2.95M 0.1%
+37,037
New +$3.39M
COGT icon
220
Cogent Biosciences
COGT
$6.65B
$2.88M 0.1%
369,763
C icon
221
Citigroup
C
$222B
$2.87M 0.1%
+40,775
New +$2.75M
AOS icon
222
A.O. Smith
AOS
$8.29B
$2.83M 0.09%
41,482
+37,380
+911% +$2.83M
CUZ icon
223
Cousins Properties
CUZ
$5.19B
$2.83M 0.09%
+92,320
New +$2.83M
ITW icon
224
Illinois Tool Works
ITW
$82.6B
$2.82M 0.09%
+11,123
New +$2.95M
FHN icon
225
First Horizon
FHN
$12.2B
$2.81M 0.09%
139,626
+95,117
+214% +$1.79M

Similar funds

Crestline Management's Q4 2024 Portfolio in Review

As of Q4 2024, Crestline Management held 889 positions worth $3.01B, up 56% from $1.92B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Crestline Management deployed $1.16B of net new capital in Q4 2024, opening 375 new positions and adding to 214 existing holdings. Its largest new stake was iShares Core S&P 500 ETF: 640,000 shares worth $377M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Broadcom, an estimated $15.8M trimmed.

  • Crestline Management's largest Q4 2024 buy was iShares Core S&P 500 ETF: 640,000 shares worth $377M.
  • Crestline Management added most to Invesco QQQ Trust in Q4 2024, an estimated $75.1M increase.
  • Crestline Management's biggest Q4 2024 reduction was Broadcom, cutting an estimated $15.8M.
  • Crestline Management fully exited State Street SPDR S&P 500 ETF Trust in Q4 2024, selling an estimated $144M.
  • Crestline Management's ten largest holdings make up 31% of its $3.01B portfolio in Q4 2024.
  • Crestline Management opened 375 new positions and closed 184 in Q4 2024.
  • Crestline Management's portfolio value rose 56% quarter-over-quarter to $3.01B.

Based on Crestline Management's 13F filing for Q4 2024, filed 14 Feb 2025.